Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126766032 | 12676603 | 2 | F | 201607 | 20160829 | 20160823 | 20160908 | EXP | US-BAYER-2016-149937 | BAYER | 49.00 | YR | A | F | Y | 64.00000 | KG | 20160908 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126766032 | 12676603 | 1 | PS | ADEMPAS | RIOCIGUAT | 1 | UNK | 204819 | TABLET | ||||||||||
| 126766032 | 12676603 | 2 | SS | AMBRISENTAN | AMBRISENTAN | 1 | Unknown | 10 MG, QD | 0 | 10 | MG | QD | |||||||
| 126766032 | 12676603 | 3 | SS | ORENITRAM | TREPROSTINIL | 1 | Oral | 4.25 MG, TID | 0 | 4.25 | MG | TID | |||||||
| 126766032 | 12676603 | 4 | SS | ORENITRAM | TREPROSTINIL | 1 | Oral | UNK | 2100397 | 0 | |||||||||
| 126766032 | 12676603 | 5 | SS | ORENITRAM | TREPROSTINIL | 1 | Oral | UNK | 2100697 | 0 | |||||||||
| 126766032 | 12676603 | 6 | SS | ORENITRAM | TREPROSTINIL | 1 | Oral | 2.75 MG, TID | 0 | 2.75 | MG | TID | |||||||
| 126766032 | 12676603 | 7 | SS | ORENITRAM | TREPROSTINIL | 1 | UNK | 2100697 | 0 | ||||||||||
| 126766032 | 12676603 | 8 | SS | ADCIRCA | TADALAFIL | 1 | UNK | 0 | |||||||||||
| 126766032 | 12676603 | 9 | C | APIXABAN | APIXABAN | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126766032 | 12676603 | 1 | Product used for unknown indication |
| 126766032 | 12676603 | 2 | Pulmonary arterial hypertension |
| 126766032 | 12676603 | 3 | Pulmonary arterial hypertension |
| 126766032 | 12676603 | 4 | Pulmonary arterial hypertension |
| 126766032 | 12676603 | 5 | Pulmonary arterial hypertension |
| 126766032 | 12676603 | 6 | Pulmonary arterial hypertension |
| 126766032 | 12676603 | 7 | Pulmonary arterial hypertension |
| 126766032 | 12676603 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126766032 | 12676603 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126766032 | 12676603 | Dizziness | |
| 126766032 | 12676603 | Dyspnoea at rest | |
| 126766032 | 12676603 | Dyspnoea exertional | |
| 126766032 | 12676603 | Flatulence | |
| 126766032 | 12676603 | Flushing | |
| 126766032 | 12676603 | Hot flush | |
| 126766032 | 12676603 | Influenza like illness | |
| 126766032 | 12676603 | Musculoskeletal chest pain | |
| 126766032 | 12676603 | Myalgia | |
| 126766032 | 12676603 | Nausea | |
| 126766032 | 12676603 | Pain | |
| 126766032 | 12676603 | Palpitations | |
| 126766032 | 12676603 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126766032 | 12676603 | 2 | 20160205 | 0 | ||
| 126766032 | 12676603 | 3 | 20150612 | 0 |